Medications for newborns undergo rigorous testing and approval processes. The FDA evaluates the safety and efficacy of drugs specifically for neonatal use. Dosages and formulations may differ significantly from those used in older children and adults, necessitating careful regulation. Off-label drug use in neonates is also closely monitored to ensure safety.
